Clinical Trials on Immune-Mediated Neuropathy in Germany

Total 3957 results

Hannover Medical School

Completed

Elimination of Cardiac and Inflammatory Biomarkers and Adipokines by Therapeutic Plasma Exchange

Antibody-mediated Rejection | Autoimmune Reaction Mediated by Immune Complex

Germany
Farsad Eskandary
Charite University, Berlin, Germany; University of Alberta; HI-Bio

Completed

Felzartamab in Late Antibody-Mediated Rejection

Antibody-mediated Rejection

Austria, Germany
Medical University of Vienna
Charite University, Berlin, Germany; University of Alberta; CSL Behring

Completed

A Pilot Trial of Clazakizumab in Late ABMR

Antibody-mediated Rejection

Austria, Germany
Charite University, Berlin, Germany

Active, not recruiting

Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection (cfDNA-DSA)

Kidney Transplant Rejection | Antibody-mediated Rejection | Kidney Transplant Failure

Germany
Christoph Stein, MD
deCODE genetics

Completed

Analysis of Markers in the Blood Correlated With Neuropathic Pain

Neuropathy

Germany
University Hospital Schleswig-Holstein

Terminated

Tapentadol Versus Oxycodon - a Mechanism-based Treatment Approach in Neuropathic Pain

Peripheral Neuropathy

Germany
Bayer

Terminated

A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain

Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Germany, Denmark, France, Poland, Finland, Czechia, Hungary, Norway, Slovakia, Sweden
Bayer

Completed

A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain

Diabetes Mellitus | Neuropathic Pain Associated With Diabetic Peripheral Neuropathy | Peripheral Neuropathic Pain

Hungary, Spain, Germany, Czechia, Slovakia, United Kingdom
CSL Behring

Terminated

Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

Antibody-mediated Rejection

United States, Spain, France, Netherlands, United Kingdom, Belgium, Germany
University of Erlangen-Nürnberg Medical School

Completed

Influence of Nitric Oxide on Flow Mediated Dilation

FMD - Flow Mediated Dilation

Germany
Eli Lilly and Company
Boehringer Ingelheim

Completed

An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain

Diabetic Neuropathy, Painful

Germany, United States
University Hospital Tuebingen
University Hospital Freiburg

Completed

Assessment of Visual Field-related Endpoints in Patients With Non-arteritic Ischemic Optic Neuropathy (Pilot-SINN)

Non-arteritic Ischemic Optic Neuropathy

Germany
ARCIM Institute Academic Research in Complementary...

Recruiting

Efficacy of External Application of Rosemary Oil in Patients With Chemotherapy-Induced Peripheral Neuropathy: a Feasibility Study

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Germany
Astellas Pharma Europe B.V.

Completed

A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety (MOBILE)

Neuropathic Pain | Post-Herpetic Neuralgia (PHN) | Painful Diabetic Peripheral Neuropathy (PDPN)

Czechia, Germany, Poland, United Kingdom
UCB Pharma
SCHWARZ BIOSCIENCES GmbH - Part of UCB Group

Completed

A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy

Painful Diabetic Neuropathy

Germany
UCB Pharma
SCHWARZ BIOSCIENCES GmbH - Part of UCB Group

Completed

A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy

Painful Diabetic Neuropathy

Germany
Alexion Pharmaceuticals

Terminated

Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization

Antibody Mediated Rejection

United States, Germany, Italy, France, United Kingdom, Spain, Sweden, Australia, Netherlands, Norway
Octapharma

Completed

Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy (CIDP)

Chronic Inflammatory Demyelinating Poly(Radiculo)Neuropathy

Canada, Poland, Romania, Ukraine, Bulgaria, Czechia, Germany, Hungary, Russian Federation
Alnylam Pharmaceuticals

Completed

Safety and Tolerability of Patisiran (ALN-TTR02) in Transthyretin (TTR) Amyloidosis

TTR-mediated Amyloidosis

Portugal, Spain, Sweden, Brazil, United States, France, Germany
Johann Wolfgang Goethe University Hospital

Completed

Safety and Feasibility Study of Autologous Progenitor Cell Transplantation in Diabetic Neuropathy

Diabetic Neuropathies

Germany
Shire

Terminated

A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant

Acute Antibody-Mediated Rejection (AMR)

United States, Spain, France, Netherlands, Germany, Canada
CSL Behring
ICON Clinical Research

Terminated

Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients (IMAGINE)

Antibody-mediated Rejection

Korea, Republic of, United States, New Zealand, Spain, Taiwan, Netherlands, Australia, France, Canada, Belgium, Czechia, Hungary, Sweden, Austria, Germany
UCB Pharma

Completed

A Trial to Assess the Efficacy and Safety of SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neuropathy

Diabetic Neuropathy

Germany
Aarhus University Hospital
University of Southern Denmark

Completed

Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabetic Polyneuropathy | Hereditary Axonal Neuropathy | Hereditary Demyelinated Neuropathy | Polyneuropathy, Inflammatory Demyelinating, Chronic

Denmark, Germany
Abbott Medical Devices

Terminated

A Post Market Cohort With the Spinal Modulation Neurostimulator System in Peripheral Neuropathy

Peripheral Neuropathy

Germany
Alnylam Pharmaceuticals

Completed

The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant

ATTR Amyloidosis | Transthyretin (TTR)-Mediated Amyloidosis | Familial Amyloidotic Polyneuropathy (FAP) | Familial Amyloid Neuropathies

France, Germany, Portugal, United Kingdom, Sweden, Spain
Benno Brinkhaus
Karl and Veronica Carstens Foundation

Completed

ACUpuncture in Diabetic Peripheral Neuropathy (ACUDPN)

Diabetic Neuropathy

Germany
Mitsubishi Tanabe Pharma Corporation

Completed

Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy

Painful Diabetic Peripheral Neuropathy

Germany, Hungary, Poland
Alnylam Pharmaceuticals

Completed

The Study of ALN-TTR02 (Patisiran) for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)

TTR-mediated Amyloidosis

Portugal, Sweden, Brazil, United States, France, Spain, Germany
RWTH Aachen University

Completed

Longterm Renal Oucomes of STOP-IgAN Trial Participants

IgA Nephropathy

Germany
University of Magdeburg
EBS Technologies GmbH

Completed

Trial of Alternating Current Stimulation in Optic Neuropathy (SCT_optnerve)

Optic Nerve Diseases | Optic Nerve Injuries | Optic Neuropathies

Germany
Bionorica Research GmbH

Completed

Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Central Neuropathic Pain Related to Multiple Sclerosis

Central Neuropathic Pain in Multiple Sclerosis

Germany
University Hospital, Essen

Recruiting

Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation

Peripheral Arterial Disease | Drug Eluting Balloon | Infrainguinal Peripheral Arterial Disease | Flow-mediated Dilation

Germany
University of Cologne

Unknown

Change of Nerve Conduction Properties in IVIg Dependent Neuropathies

Guillain-Barre Syndrome | CIDP | Multifocal Motor Neuropathy

Germany
Technical University of Munich

Completed

Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy (ATHENS)

Kidney Diseases | Renal Failure | Adverse Effects | Contrast Induced Nephropathy

Germany
Eli Lilly and Company
Boehringer Ingelheim

Completed

Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)

Diabetic Neuropathies

Germany, France, Italy, Brazil
Rigel Pharmaceuticals

Completed

Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy

IGA Nephropathy

United States, United Kingdom, Hong Kong, Taiwan, Austria, Germany
Universität Duisburg-Essen

Completed

Complementary and Integrative Therapy for Diabetic Neuropathy (CIT-DN)

Diabetes Mellitus, Type 2 | Diabetic Neuropathy

Germany
University of Magdeburg
EBS Technologies GmbH

Completed

Paraorbital-Occipital Alternating Current Stimulation Therapy for Optic Neuropathy (MCT_optnerve)

Optic Nerve Diseases | Optic Nerve Injuries | Optic Neuropathies

Germany
Lorenz Biotech S.p.A.

Completed

Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy

Diabetic Neuropathy, Painful

France, Germany, Italy
argenx

Recruiting

A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy (ARDA+)

Multifocal Motor Neuropathy (MMN)

United Kingdom, Spain, United States, Italy, Netherlands, Germany, France, Belgium, Canada, Poland, Austria
Technical University of Munich
University Hospital, Essen; University of Erlangen-Nürnberg; Heinrich-Heine University... and other collaborators

Terminated

Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation (Rituximab 2006)

Renal Transplantation | Transplantation, Kidney | Chronic Allograft Nephropathy | Grafting

Germany
Glenmark Pharmaceuticals Ltd. India
Glenmark Pharmaceuticals S.A.

Withdrawn

A Clinical Trial to Study the Effects of GRC 17536 in Patients With Painful Diabetic Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients)

Painful Diabetic Neuropathy

Germany, United Kingdom
UCB Pharma

Completed

An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide in Subjects With Chronic Refractory Neuropathic Pain

Chronic Refractory Neuropathic Pain

Germany
RWTH Aachen University
Grünenthal GmbH

Recruiting

Biometric and Biological Data for Diagnosis and Therapy of Pain Patients (Bio2Treat)

Small Fiber Neuropathy

Germany
RWTH Aachen University

Completed

Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy (STOP-IgAN)

IgA Nephropathy

Germany
Apurano Pharmaceuticals GmbH

Recruiting

Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy

Pain | Chronic Pain | Neuropathic Pain | Peripheral Neuropathy | Pain, Chronic | Post Operative Pain | Chronic Pain Syndrome | Pain Syndrome | Peripheral Nerve Injury | Post-Traumatic Neuralgia | Peripheral Neuralgia | Plexopathy

Germany
University of Giessen
Novartis; Hoffmann-La Roche; Astellas Pharma Inc; Heidelberg University

Completed

Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy

Polyomavirus Infections

Germany
Apurano Pharmaceuticals GmbH

Recruiting

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy

Pain | Chronic Pain | Neuropathic Pain | Peripheral Neuropathy | Pain, Chronic | Post Operative Pain | Chronic Pain Syndrome | Pain Syndrome | Peripheral Nerve Injury | Post-Traumatic Neuralgia | Peripheral Neuralgia | Plexopathy

Germany
Prof Herta Flor
Heidelberg University

Completed

Cortical Representation of Hyperalgesia Induced by Nerve Growth Factor (LOGIN_NGF)

Healthy Subjects | Non-inflammatory Neuropathic Pain

Germany

Clinical Trials on Immune-Mediated Neuropathy in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations